Starlight Cardiovascular, Inc.
San Diego, CA
- UEI
- W3TSK3T9QHJ7
- CAGE
- 8NXF0
- Primary NAICS
- 339112 Surgical and Medical Instrument Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 9710 Scranton Rd #100, San Diego, CA 92121, USA
- Website
- starlightcardio.com
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Heartpoint Global Inc. | Miami, FL | 339112 Surgical and Medical Instrument Manufacturing |
| Corvion, Inc. | Webster, TX | 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing |
| Coridea, LLC | New York, NY | 541690 Other Scientific and Technical Consulting Services |
| Sirona Medical Technologies, Inc. | Windsor, CT | 339112 Surgical and Medical Instrument Manufacturing |
| Minnesota Healthsolutions Corporation | Minneapolis, MN | 541330 Engineering Services |
About the company
Starlight Cardiovascular, Inc. is a San Diego-based medical device company that receives federal research funding as a grant recipient from the National Heart, Lung, and Blood Institute (NHLBI) under the Small Business Innovation Research (SBIR) program to develop catheter-delivered cardiovascular devices for congenital heart defects in neonates. The vendor operates exclusively as a prime recipient on federal grants; it holds no federal contracts, has not won any contract vehicles, and has no subcontractor engagements in federal work.
Starlight's federal footprint is concentrated entirely within the Department of Health and Human Services. Across six SBIR Project Grants awarded since 2021, all funded by NHLBI under CFDA 93.837 (Cardiovascular Diseases Research), the combined obligated value is $21.4 million, with a single customer agency (NHLBI) accounting for 100% of awards. The company's capability portfolio centers on two pediatric interventional cardiology devices: a catheter-delivered, adjustable percutaneous pulmonary flow restrictor designed to replace surgical pulmonary artery banding in newborns with hypoplastic left heart syndrome and other congenital heart defects; and a ductus arteriosus stent engineered to maintain ductus patency in ductal-dependent congenital heart conditions without requiring open-chest surgery on neonates.
Representative grants include an $499,952 award dated August 10, 2026 (ultimate completion July 31, 2027) for commercialization readiness of the pulmonary flow restrictor; a $499,952 award dated September 15, 2024 (ultimate completion February 28, 2026) for the ductus arteriosus stent; and two earlier Phase I and Phase II SBIR grants dated February 15, 2022 for pulmonary flow restrictor development, one expiring July 31, 2029 and one expiring January 31, 2023. Two awards face completion within the next twenty-four months and will enter recompete. The company's work is performed in San Diego, California, and focuses on FDA-approvable device design, preclinical testing, manufacturing process finalization, and investigational device exemption preparation.
Quick answers
Is Starlight Cardiovascular, Inc. registered in SAM.gov?
Yes. Starlight Cardiovascular, Inc.'s SAM.gov registration is active through July 24, 2027.
What is Starlight Cardiovascular, Inc.'s CAGE code?
Starlight Cardiovascular, Inc.'s CAGE code is 8NXF0, and its Unique Entity ID (UEI) is W3TSK3T9QHJ7.
What is Starlight Cardiovascular, Inc.'s most recent federal award?
Starlight Cardiovascular, Inc.'s most recent federal grant award is Commercialization readiness of a pulmonary flow restrictor for hypoplastic left heart syndrome (SB1HL184388), from National Heart Lung and Blood Institute (NIH), on August 10, 2026.
On GovTribe
See Starlight Cardiovascular, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors